Authors:
Van Laethem, K
Schmit, JC
Pelemans, H
Balzarini, J
Witvrouw, M
Perez-Perez, MJ
Camarasa, MJ
Esnouf, RM
Aquaro, S
Cenci, A
Perno, CF
Hermans, P
Sprecher, S
Ruiz, L
Clotet, B
Van Wijngaerden, E
Van Ranst, M
Desmyter, J
De Clercq, E
Vandamme, AM
Citation: K. Van Laethem et al., Presence of 2 ',5 '-bis-O-(tert-butyldimethylsilyl)-3 '-spiro-5 ''-(4 ''-amino-1 '',2 ''-oxathiole-2 '',2 ''-dioxide) (TSAO)-resistant virus strains in TSAO-inexperienced HIV patients, AIDS RES H, 16(9), 2000, pp. 825-833
Authors:
Lescrinier, E
Esnouf, RM
Schraml, J
Busson, R
Herdewijn, P
Citation: E. Lescrinier et al., Solution structure of a hexitol nucleic acid duplex with four consecutive T center dot T base pairs, HELV CHIM A, 83(7), 2000, pp. 1291-1310
Authors:
Luyten, I
Esnouf, RM
Mikhailov, SN
Efimtseva, EV
Michiels, P
Heus, HA
Hilbers, CW
Herdewijn, P
Citation: I. Luyten et al., Solution structure of a RNA decamer duplex, containing 9-[2-O-(beta-D-ribofuranosyl)-beta-D-ribofuranosyl]adenine, a special residue in lower eukaryotic initiator tRNAs, HELV CHIM A, 83(6), 2000, pp. 1278-1289
Citation: Rm. Esnouf, Further additions to MolScript version 1.4, including reading and contouring of electron-density maps, ACT CRYST D, 55, 1999, pp. 938-940
Authors:
Ren, JS
Esnouf, RM
Hopkins, AL
Stuart, DI
Stammers, DK
Citation: Js. Ren et al., Crystallographic analysis of the binding modes of thiazoloisoindolinone non-nucleoside inhibitors to HIV-1 reverse transcriptase and comparison with modeling studies, J MED CHEM, 42(19), 1999, pp. 3845-3851
Authors:
Pelemans, H
Esnouf, RM
Jonckheere, H
De Clercq, E
Balzarini, J
Citation: H. Pelemans et al., Mutational analysis of Tyr-318 within the non-nucleoside reverse transcriptase inhibitor binding pocket of human immunodeficiency virus type I reverse transcriptase, J BIOL CHEM, 273(51), 1998, pp. 34234-34239